NCT06277947View on ClinicalTrials.gov

Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward

NANot yet recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

May 31, 2025

Conditions
Epithelial Ovarian Cancer
Interventions
PROCEDURE

China Hyperthermic Intraperitoneal Chemotherapy(C-HIPEC)

The C-HIPEC would be performed at bedside in the general ward within 24 hours after surgery. The HIPEC treatment instruments are BR-TRG-II system, which can control the temperature stably to 43℃±0.1℃.

Trial Locations (1)

Unknown

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors
collaborator

Shenshan Medical Center, Memorial Hospital of Sun Yat-sen University

UNKNOWN

lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT06277947 - Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward | Biotech Hunter | Biotech Hunter